Skip to content

Substance use initiation: The role of simultaneous polysubstance use

Janine V. Olthuis, Christine Darredeau, Sean P. Barrett

Drug and Alcohol Review May 21, 2012 DOI: 10.1111/j.1465-3362.2012.00470.x (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional study Peer reviewed
Sample size 226
Population Cannabis users
Topics Cannabis MDMA Mescaline Psilocybin
Keywords Polysubstance dependence Heroin Substance use Amphetamine Substance abuse Hallucinogen Drug
Citations 79
Key findings A clear majority of cannabis users (≥75%) reported simultaneous polysubstance use during their first-ever use of most illicit substances, with alcohol, tobacco, or cannabis commonly co-administered.

Abstract

Abstract Introduction and Aims. Simultaneous polysubstance use (SPU) is a common phenomenon, yet little is known about its role in substance use initiation. Design and Methods. In the present study, 226 cannabis users completed structured interviews about their substance use history. For each substance ever used, participants provided details of their age of first use, their use in the preceding 30 days and whether they co‐administered any other licit or illicit substances the first time they used the substance. Results. For most illicit substances [powder cocaine, crack, amphetamine, methamphetamine, 3,4‐methylenedioxymethamphetamine (MDMA; ecstasy), heroin, opium, gamma‐hydroxybutyric acid (GHB), ketamine, psilocybin (magic mushrooms), mescaline, phencyclidine (PCP), peyote and inhalants], results showed that a clear majority of participants ( ≥ 75%) reported SPU during their first‐ever use of the substance. While SPU was less common on occasions of first use of alcohol, tobacco and cannabis, a high proportion of SPU on occasions of first use of ‘harder’ drugs could be accounted for by the co‐use of alcohol, tobacco and/or cannabis. Discussion and Conclusions. Such findings raise the possibility that specific alcohol, tobacco and/or cannabis use episodes might directly contribute to the initiation of new substance use. Understanding the role of SPU on occasions of first use might help better identify risk factors for substance use progression and improve intervention efforts. [Olthuis JV, Darredeau C, Barrett SP. Substance use initiation: The role of simultaneous polysubstance use. Drug Alcohol Rev 2013;32:67–71]

Comparable studies

Other cross-sectional and survey studies on mescaline, most cited first.

Study Year Design Participants
Psychedelics and Mental Health: A Population Study Adult population in the United States 2013 Cross-sectional survey n = 130,152
Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness General population online sample 2017 Cross-sectional survey n = 1,487
Voice of the Psychonauts: Coping, Life Purpose, and Spirituality in Psychedelic Drug Users Psychedelic drug users, other drug users, and drug nonusers 2011 Cross-sectional survey n = 667
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes. Adults reporting use of mescaline in naturalistic settings 2021 Cross-sectional survey n = 452
Acute Adverse Reactions to Lsd in Clinical and Experimental use in the United Kingdom Subjects in LSD or mescaline sessions 1971 Survey n = 5,000

Citations in the library

Explore topics